ArticlePloS one2026
β-Galactosidase expression on Lactococcus sp. KTH0-1S as a whole-cell biocatalyst for efficient lactosucrose production.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lactosucrose is a functional trisaccharide with prebiotic properties and growing potential in food and agricultural applications; however, its industrial production is limited by low conversion efficiency and high downstream processing costs. In this study, a whole-cell biocatalyst was developed by displaying β-galactosidase on Lactococcus sp. KTH0-1S using a nisin-inducible expression system, the USP45 signal peptide, and a LysM anchoring domain. The engineered strain exhibited a maximum whole-cell β-galactosidase activity of 146.0 Miller units after 4 h of induction. The whole-cell enzyme efficiently catalyzed lactosucrose synthesis from lactose and sucrose, with optimal activity observed at pH 6.0 and 50 °C. Substrate molar ratio significantly influenced product formation, and the highest lactosucrose concentration (15,940 mg/L) was achieved at a lactose:sucrose ratio of 1:3. Reusability studies revealed high initial catalytic activity but limited stability upon repeated reaction cycles, likely due to the non-covalent nature of LysM-mediated surface anchoring. Molecular docking analysis supported the experimental observations by identifying a high-affinity substrate-binding pocket capable of accommodating both donor and acceptor substrates, providing a structural rationale for enhanced transgalactosylation under sucrose-enriched conditions. Overall, this study demonstrates the feasibility of using a whole-cell biocatalyst based on Lactococcus sp. for efficient lactosucrose production and highlights its potential as a cost-effective and food-compatible platform for the synthesis of functional oligosaccharides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.